Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEMA6D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RHOJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGI4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CCT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFTR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UHRF1BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMCHL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CEP170P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL6IP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIFC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BORCS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAGLROS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC17A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on